- Home
- / Vimian Group
Vimian Group
Stock Price
KR45.3
2024-10-29
Market Capitalization
KR23.7 B
2024-10-29
Revenue
€331.7 M
FY, 2023
Vimian Group Summary
Company Summary
- Overview
- Vimian Group is a provider of animal health services. It specializes in proprietary diagnostics, prescription and non-prescription treatments, procurement, tech-driven operations applications, etc. The company also offers molecular and immunodiagnostic solutions.
- Type
- Public
- Status
- Active
- Founded
- 2021
- HQ
- Stockholm, SE | view all locations
- Website
- https://vimian.com/
- Cybersecurity rating
Table of Contents
Vimian Group Financials
Summary Financials
- Revenue (Q3, 2024)
- €87.6M
- Gross profit (Q3, 2024)
- €61.1M
- Net income (Q3, 2024)
- (€1.9M)
- Cash (Q3, 2024)
- €39.2M
- EBIT (Q3, 2024)
- €10.1M
- Enterprise value
- $23.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025